Pereira Nicola M, Drusin Madeleine A, Modi Vikash K
Weill Cornell Medical College, New York Presbyterian Hospital / Department of Otolaryngology - Head & Neck Surgery/Division of Pediatric Otolaryngology-Head & Neck Surgery, 428 East 72nd St., Suite 100, New York, NY, USA.
New York Presbyterian Hospital, University Hospitals of Columbia & Cornell, Department of Otolaryngology - Head & Neck Surgery, 1305 York Ave, Suite 5F, New York, NY, USA.
Auris Nasus Larynx. 2023 Feb;50(1):119-125. doi: 10.1016/j.anl.2022.05.014. Epub 2022 Jun 2.
To discuss our institutional experience with endoscopic management of intralingual thyroglossal duct cyst (TGDC) and review cases in the published literature in a systematic review.
Pediatric patients with intralingual TGDC treated with endoscopic surgery at our institution from 2009-2019 were identified. Metrics from our case series were then compared to those in the literature in a systematic review to assess pooled outcomes of endoscopic or transoral management. Patient demographics, age of presentation, presenting symptomatology, size of cyst on imaging, type of surgery, and post-operative outcomes were assessed.
We identified 5 institutional cases of intralingual TGDC and 48 cases of intralingual TGDC described in the literature. The average age of presentation was 20.36 months. 69.8% (N=37) of patients presented with at least one respiratory symptom, 22.6% (N=12) presented with dysphagia, 9.4% (N=5) presented with an identified mass in the oropharynx, and 15.1% (N=8) had the cyst discovered as an incidental finding. Three patients required revision surgeries due to prior incomplete TGDC excisions and one patient experienced a recurrence >6 months after primary excision requiring a second procedure. Our data pooled with published case series in systematic review confirms that endoscopic or transoral management are excellent options for definitive management of intralingual TGDC.
Intralingual TDGC is a potentially life-threatening variant of TGDC. Our results pooled with published series in a systematic review suggest that endoscopic or transoral management of intralingual TGDC are excellent minimally invasive treatments with a low risk of recurrence. Postoperative surveillance up to one year is recommended.
探讨我院内镜治疗舌内甲状舌管囊肿(TGDC)的经验,并通过系统评价回顾已发表文献中的病例。
确定2009年至2019年在我院接受内镜手术治疗的舌内TGDC儿科患者。然后将我们病例系列中的指标与文献中的指标进行系统评价比较,以评估内镜或经口治疗的汇总结果。评估患者的人口统计学特征、就诊年龄、临床表现、影像学上囊肿大小、手术类型和术后结果。
我们确定了5例我院舌内TGDC病例和文献中描述的48例舌内TGDC病例。平均就诊年龄为20.36个月。69.8%(N = 37)的患者至少出现一种呼吸道症状,22.6%(N = 12)出现吞咽困难,9.4%(N = 5)在口咽处发现肿物,15.1%(N = 8)的囊肿是偶然发现的。3例患者因先前甲状舌管囊肿切除不完全而需要再次手术,1例患者在初次切除后6个月以上复发,需要进行第二次手术。我们的数据与系统评价中已发表的病例系列汇总后证实,内镜或经口治疗是舌内TGDC确定性治疗的极佳选择。
舌内甲状舌管囊肿是甲状舌管囊肿的一种潜在危及生命的变体。我们的结果与系统评价中已发表的系列汇总表明,舌内TGDC的内镜或经口治疗是极佳的微创治疗方法,复发风险低。建议术后进行长达一年的监测。